{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:07:13Z","timestamp":1789499233000,"version":"build-2803163510"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FFU"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec>\n<jats:title>\nBackground\n<\/jats:title>\n<jats:p>Bariatric surgery may affect the pharmacokinetics of medications by altering the gastrointestinal physiology. Pharmacokinetic changes of first-line neuropathic pain medications such as gabapentin and pregabalin following bariatric treatment have barely been investigated.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>\nMethods\n<\/jats:title>\n<jats:p>In our prospective five-case study we included gabapentin- or pregabalin-treated patients undergoing bariatric surgery at hospitals in Central Norway. Concentrations of gabapentin and pregabalin were assessed using serial blood samples over a dose interval, preoperatively and one, six and twelve months postoperatively. The primary outcomes of the study included changes in area under the time-concentration curve (AUC) with secondary outcomes comprising full pharmacokinetic profiling. Formal statistical testing was not performed due to few cases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>\nResults\n<\/jats:title>\n<jats:p>Three pregabalin-treated obese patients undergoing Roux-en-Y gastric bypass (RYGB) and two gabapentin-treated patients undergoing RYGB (n\u2009=\u20091) and sleeve gastrectomy (SG) (n\u2009=\u20091) were included. Largest changes for dose-adjusted AUC values after surgery were seen in pregabalin-treated patients at one and six months (average increases of 53% one month and 28% 6 months postoperatively). In the patients on gabapentin, mean AUC changes were less than 10% from baseline throughout the study period. The inter-individual variation was high.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>\nConclusion\n<\/jats:title>\n<jats:p>Postoperative pharmacokinetic changes for gabapentin were minimal, but for pregabalin we observed more pronounced changes, particularly in one patient. Due to few cases, the results should be interpreted with caution. Given the large inter-individual variation, therapeutic drug monitoring could be considered to capture pharmacokinetic changes and guide dose adjustments postoperatively.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0319912","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:46:46Z","timestamp":1743018406000},"page":"e0319912","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of sleeve gastrectomy and Roux-en-Y gastric bypass on the pharmacokinetics of gabapentin and pregabalin: A cohort study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-4117","authenticated-orcid":true,"given":"Georgios","family":"Schoretsanitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege-Merete","family":"Krabseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4686-0263","authenticated-orcid":true,"given":"Magnus","family":"Str\u00f8mmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-1253","authenticated-orcid":true,"given":"Arne","family":"Helland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7902-9014","authenticated-orcid":true,"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"1","key":"pone.0319912.ref001","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1038\/s41598-024-54141-6","article-title":"Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus","volume":"14","author":"M Kermansaravi","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0319912.ref002","author":"American Society for Metabolic and Bariatric Surgery","year":"2024"},{"issue":"11","key":"pone.0319912.ref003","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/obr.12434","article-title":"Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations","volume":"17","author":"C Azran","year":"2016","journal-title":"Obes Rev"},{"issue":"3","key":"pone.0319912.ref004","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"MF Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"pone.0319912.ref005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12893-024-02438-8","article-title":"Prevention of malnutrition after one anastomosis gastric bypass: value of the common channel limb length","volume":"24","author":"E Mostafapour","year":"2024","journal-title":"BMC Surg"},{"issue":"1","key":"pone.0319912.ref006","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12893-023-02175-4","article-title":"Bariatric and metabolic surgery in patients with low body mass index: an online survey of 543 bariatric and metabolic surgeons","volume":"23","author":"SS Shahmiri","year":"2023","journal-title":"BMC Surg"},{"issue":"2","key":"pone.0319912.ref007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diabet.2013.11.003","article-title":"Gastrointestinal changes after bariatric surgery","volume":"40","author":"I Quercia","year":"2014","journal-title":"Diabetes Metab"},{"issue":"9","key":"pone.0319912.ref008","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1111\/bcp.15349","article-title":"Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity","volume":"88","author":"KE Kvitne","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"pone.0319912.ref009","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/cts.13142","article-title":"Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trial","volume":"15","author":"KE Kvitne","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"1","key":"pone.0319912.ref010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3344\/kjp.2020.33.1.3","article-title":"Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis","volume":"33","author":"M Davari","year":"2020","journal-title":"Korean J Pain"},{"issue":"8","key":"pone.0319912.ref011","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1007\/s11695-022-06109-6","article-title":"Analgesic efficacy of gabapentin and pregabalin in patients undergoing laparoscopic bariatric surgeries: a systematic review and meta-analysis","volume":"32","author":"K-C Hung","year":"2022","journal-title":"Obes Surg"},{"issue":"2","key":"pone.0319912.ref012","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jopan.2022.04.017","article-title":"Efficacy and safety of gabapentin on postoperative pain management after bariatric surgery: a systematic review and meta-analysis","volume":"38","author":"TD Tubog","year":"2023","journal-title":"J Perianesth Nurs"},{"issue":"5","key":"pone.0319912.ref013","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain - is increased prescribing a cause for concern?","volume":"377","author":"CW Goodman","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0319912.ref014","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/j.pain.0000000000001612","article-title":"The contribution of obesity to prescription opioid use in the United States","volume":"160","author":"A Stokes","year":"2019","journal-title":"Pain"},{"issue":"12","key":"pone.0319912.ref015","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00228-021-03182-1","article-title":"Serum concentrations of antidepressants, antipsychotics, and antiepileptics over the bariatric surgery procedure","volume":"77","author":"SM Wallerstedt","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"pone.0319912.ref016","first-page":"805","article-title":"Effects of sleeve gastrectomy and roux-en-y gastric bypass on escitalopram pharmacokinetics: a cohort study","volume":"45","author":"G Schoretsanitis","year":"2023","journal-title":"Ther Drug Monit"},{"issue":"10","key":"pone.0319912.ref017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"HN Bockbrader","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"1\u201302","key":"pone.0319912.ref018","first-page":"9","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"C Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"pone.0319912.ref019","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of pregabalin in subjects with various degrees of renal function","volume":"43","author":"EJ Randinitis","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"pone.0319912.ref020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.jrn.2014.01.016","article-title":"The beneficial effects of weight reduction in overweight patients with chronic proteinuric immunoglobulin a nephropathy: a randomized controlled trial","volume":"24","author":"P Kittiskulnam","year":"2014","journal-title":"J Ren Nutr"},{"issue":"8","key":"pone.0319912.ref021","doi-asserted-by":"crossref","first-page":"e2423385","DOI":"10.1001\/jamanetworkopen.2024.23385","article-title":"Disproportionality analysis from world health organization data on semaglutide, liraglutide, and suicidality","volume":"7","author":"G Schoretsanitis","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:48:01Z","timestamp":1743018481000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0319912"}},"subtitle":[],"editor":[{"given":"Yee Gary","family":"Ang,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0319912","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}